These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3330 related articles for article (PubMed ID: 9379138)

  • 21. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
    J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor.
    Swamy N; Mohr SC; Xu W; Ray R
    Arch Biochem Biophys; 1999 Mar; 363(2):219-26. PubMed ID: 10068443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element.
    Hakim I; Bar-Shavit Z
    J Cell Biochem; 2003 Apr; 88(5):986-98. PubMed ID: 12616536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.
    Malloy PJ; Hochberg Z; Tiosano D; Pike JW; Hughes MR; Feldman D
    J Clin Invest; 1990 Dec; 86(6):2071-9. PubMed ID: 2174914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL; Leong GM; Sutherland RL; Eisman JA
    J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance.
    Cheskis B; Freedman LP
    Biochemistry; 1996 Mar; 35(10):3309-18. PubMed ID: 8605168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
    Manolagas SC; Yu XP; Girasole G; Bellido T
    Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.
    Yoshizawa T; Handa Y; Uematsu Y; Takeda S; Sekine K; Yoshihara Y; Kawakami T; Arioka K; Sato H; Uchiyama Y; Masushige S; Fukamizu A; Matsumoto T; Kato S
    Nat Genet; 1997 Aug; 16(4):391-6. PubMed ID: 9241280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic actions of 1,25-dihydroxyvitamin D3.
    Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
    J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 167.